192 related articles for article (PubMed ID: 21034499)
1. Prognostic significance of nuclear survivin expression in resected adenoid cystic carcinoma of the head and neck.
Ko YH; Roh SY; Won HS; Jeon EK; Hong SH; Lee MA; Kang JH; Hong YS; Kim MS; Jung CK
Head Neck Oncol; 2010 Oct; 2():30. PubMed ID: 21034499
[TBL] [Abstract][Full Text] [Related]
2. Adenoid cystic carcinoma of the lacrimal gland: role of nuclear survivin (BIRC5) as a prognostic marker.
Mulay K; Puthyapurayil FM; Mohammad JA; Hasnat Ali M; Honavar SG; Reddy VA
Histopathology; 2013 May; 62(6):840-6. PubMed ID: 23611357
[TBL] [Abstract][Full Text] [Related]
3. Survivin and pAkt as potential prognostic markers in squamous cell carcinoma of the head and neck.
Pickhard A; Gröber S; Haug AK; Piontek G; Wirth M; Straßen U; Rudelius M; Reiter R
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):733-42. PubMed ID: 24726415
[TBL] [Abstract][Full Text] [Related]
4. Expression of beclin 1 in primary salivary adenoid cystic carcinoma and its relation to Bcl-2 and p53 and prognosis.
Jiang LC; Huang SY; Zhang DS; Zhang SH; Li WG; Zheng PH; Chen ZW
Braz J Med Biol Res; 2014 Feb; 47(3):252-8. PubMed ID: 24554038
[TBL] [Abstract][Full Text] [Related]
5. Expression of autophagy and ER stress-related proteins in primary salivary adenoid cystic carcinoma.
Jiang L; Huang S; Li W; Zhang D; Zhang S; Zhang W; Zheng P; Chen Z
Pathol Res Pract; 2012 Nov; 208(11):635-41. PubMed ID: 23089287
[TBL] [Abstract][Full Text] [Related]
6. High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer.
Erpolat OP; Gocun PU; Akmansu M; Karakus E; Akyol G
Strahlenther Onkol; 2012 Mar; 188(3):248-54. PubMed ID: 22311150
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y
Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215
[TBL] [Abstract][Full Text] [Related]
8. Adenoid cystic carcinoma: use of cell proliferation, BCL-2 expression, histologic grade, and clinical stage as predictors of clinical outcome.
Norberg-Spaak L; Dardick I; Ledin T
Head Neck; 2000 Aug; 22(5):489-97. PubMed ID: 10897109
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns and prognostic significance of inhibitor of apoptosis proteins in adenoid cystic carcinoma and pleomorphic adenoma of lachrymal gland.
Liao Y; Zeng H; Wang X; Huang Y; Chen N; Ge B; Tang L; Luo Q
Exp Eye Res; 2009 Jan; 88(1):4-11. PubMed ID: 18955046
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of apoptosis and apoptosis-associated proteins in salivary gland adenoid cystic carcinoma.
Jia L; Esguerra RL; Tang X; Yin H; Sakamoto K; Okada N; Takagi M
Pathol Int; 2004 Apr; 54(4):217-23. PubMed ID: 15028021
[TBL] [Abstract][Full Text] [Related]
11. Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer.
Rexhepaj E; Jirstrom K; O'Connor DP; O'Brien SL; Landberg G; Duffy MJ; Brennan DJ; Gallagher WM
BMC Cancer; 2010 Nov; 10():639. PubMed ID: 21092276
[TBL] [Abstract][Full Text] [Related]
12. Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer.
Brennan DJ; Rexhepaj E; O'Brien SL; McSherry E; O'Connor DP; Fagan A; Culhane AC; Higgins DG; Jirstrom K; Millikan RC; Landberg G; Duffy MJ; Hewitt SM; Gallagher WM
Clin Cancer Res; 2008 May; 14(9):2681-9. PubMed ID: 18451232
[TBL] [Abstract][Full Text] [Related]
13. Low SOX2 expression marks a distinct subset of adenoid cystic carcinoma of the head and neck and is associated with an advanced tumor stage.
Thierauf J; Weissinger SE; Veit JA; Affolter A; Laureano NK; Beutner D; Heiduschka G; Kadletz L; Meyer M; Quaas A; Plinkert P; Hoffmann TK; Hess J
PLoS One; 2018; 13(3):e0194989. PubMed ID: 29596469
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis-related (survivin, Bcl-2), tumor suppressor gene (p53), proliferation (Ki-67), and non-receptor tyrosine kinase (Src) markers expression and correlation with clinicopathologic variables in 60 thymic neoplasms.
Khoury T; Arshad A; Bogner P; Ramnath N; Zhang S; Chandrasekhar R; Wilding G; Alrawi S; Tan D
Chest; 2009 Jul; 136(1):220-228. PubMed ID: 19318677
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of survivin in pancreatic endocrine tumors.
Ekeblad S; Lejonklou MH; Stålberg P; Skogseid B
World J Surg; 2012 Jun; 36(6):1411-8. PubMed ID: 22089920
[TBL] [Abstract][Full Text] [Related]
17. Patterns of recurrence and survival of head and neck adenoid cystic carcinoma after definitive resection.
Oplatek A; Ozer E; Agrawal A; Bapna S; Schuller DE
Laryngoscope; 2010 Jan; 120(1):65-70. PubMed ID: 19877226
[TBL] [Abstract][Full Text] [Related]
18. Radiation-induced sarcoma in the head and neck region: a clinicopathologic and immunohistochemical study of 13 cases.
Wei Z; Xu J; Zeng X; Luo Y; Chen F; Yang Y; Huang Q; Xie Y
Asian Pac J Cancer Prev; 2011; 12(11):2995-9. PubMed ID: 22393978
[TBL] [Abstract][Full Text] [Related]
19. Survivin expression and impact on head and neck cancer outcomes.
Khan SA; Burke M; Zhu F; Yang DH; Dubyk C; Mehra R; Lango MJ; Ridge JA; Sher DJ; Burtness B
Oral Oncol; 2021 Jan; 112():105049. PubMed ID: 33221541
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic implications of Myb and Beta-catenin expression in adenoid cystic carcinoma.
Park S; Vora M; van Zante A; Humtsoe J; Kim HS; Yom S; Agarwal S; Ha P
J Otolaryngol Head Neck Surg; 2020 Jul; 49(1):48. PubMed ID: 32650834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
